The clinical evidence of epilepsy in patients with CMT [53,54,55,56] and hypermethylation of SBF1 in patients with Drug-resistant Temporal Lobe Epilepsy [57] highlights the role of the SBF1 gene in epilepsy. This evidence concerns the gene SBF1 and epilepsy.